Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 1
1998 2
1999 2
2000 4
2001 1
2002 1
2003 2
2004 4
2005 5
2006 6
2007 2
2008 2
2009 4
2010 2
2011 3
2013 2
2014 1
2015 2
2016 4
2017 4
2018 4
2019 4
2020 8
2021 6
2022 9
2023 4
2024 8
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 40380307

101 results

Results by year

Filters applied: . Clear all
Page 1
An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Jambulingam P, Kuttiatt VS, Krishnamoorthy K, Subramanian S, Srividya A, Raju HKK, Rahi M, Somani RK, Suryaprakash MK, Dwivedi GP, Weil GJ. Jambulingam P, et al. PLoS Negl Trop Dis. 2021 Feb 16;15(2):e0009069. doi: 10.1371/journal.pntd.0009069. eCollection 2021 Feb. PLoS Negl Trop Dis. 2021. PMID: 33591979 Free PMC article. Clinical Trial.
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Supali T, Djuardi Y, Christian M, Iskandar E, Alfian R, Maylasari R, Destani Y, Lomiga A, Minggu D, Lew D, Bogus J, Weil GJ, Fischer PU. Supali T, et al. PLoS Negl Trop Dis. 2021 Mar 29;15(3):e0009294. doi: 10.1371/journal.pntd.0009294. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33780481 Free PMC article. Clinical Trial.
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Tavul L, Laman M, Howard C, Kotty B, Samuel A, Bjerum C, O'Brian K, Kumai S, Amuga M, Lorry L, Kerry Z, Kualawi M, Karl S, Makita L, John LN, Bieb S, Wangi J, Weil GJ, Goss CW, Tisch DJ, Pomat W, King CL, Robinson LJ. Tavul L, et al. PLoS Negl Trop Dis. 2022 Feb 9;16(2):e0010096. doi: 10.1371/journal.pntd.0010096. eCollection 2022 Feb. PLoS Negl Trop Dis. 2022. PMID: 35139070 Free PMC article. Clinical Trial.
Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.
Njenga SM, Kanyi H, Okoyo C, Githinji E, Mwatele C, Matendechero SH, Omondi WP, Gitahi PN, Owaga C, Onsongo JK, Gass K. Njenga SM, et al. PLoS Negl Trop Dis. 2024 Jul 8;18(7):e0011942. doi: 10.1371/journal.pntd.0011942. eCollection 2024 Jul. PLoS Negl Trop Dis. 2024. PMID: 38976718 Free PMC article.
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Dubray CL, Sircar AD, Beau de Rochars VM, Bogus J, Direny AN, Ernest JR, Fayette CR, Goss CW, Hast M, O'Brian K, Pavilus GE, Sabin DF, Wiegand RE, Weil GJ, Lemoine JF. Dubray CL, et al. PLoS Negl Trop Dis. 2020 Jun 8;14(6):e0008298. doi: 10.1371/journal.pntd.0008298. eCollection 2020 Jun. PLoS Negl Trop Dis. 2020. PMID: 32511226 Free PMC article. Clinical Trial.
101 results